Table 2 Primary and secondary outcomes
Outcomes | Results |
|---|---|
Short-term treatment failure (%) | |
Total, n (%) | 4 (6.3) |
< 29 week, n (%) | 3 (11.5) |
ELBW, n (%) | 2 (13.3) |
SGA, n (%) | 0 (0.0) |
Long-term treatment failure (%) | |
Total, n (%) | 17 (26.6) |
• Mild BDP | 13 (20%) |
• Moderate BDP | 3 (4.5%) |
• Severe BDP | 1 (1.5%) |
< 29 week, n (%) | 14 (53.9) |
ELBW, n (%) | 8 (53.3) |
SGA, n (%) | 2 (11.1) |
Adverse event, morbidity, mortality (%) | |
Barotrauma and nasal ulceration, n (%) | 0 (0.0) |
Late onset sepsis, n (%) | 10 (16.1) |
IVH, n (%) | 0 (0.0) |
ROP, n (%) | 5 (7.8) |
NEC, n (%) | 1 (1.6) |
PDA, n (%) | 6 (9.4) |
Exitus, n (%) | 0 (0.0) |
Duration of HFNCT, mean (DS), h | 141.1 (±181.1) |
Median, | 72.5 |
Min-max | 12–720 |
Maximum flow rates, mean (DS), lpm | 7.3 (±0.9) |
Median, | 7,5 |
Min-max | 4,5–10 |
Maximum FiO2, mean (DS), % | 28.1 (±6.5) |
Median, | 25,5 |
Min-max | 21–50 |
Parenteral nutrition duration, mean (DS), days | 13.0 (±9.3) |
Median, | 10 |
Min-max | 2–42 |
Time to reach full enteral feeding, mean (DS), days | 14.6 (±9.4) |
Median, | 11 |
Min-max | 6–49 |
Time to bottle feed, mean (DS), days | 32.1 (±15.0) |
Median, | 33 |
Min-max | 7–85 |
Length of hospitalization, mean (DS), days | 52.4 (±20.0) |
Median, | 49 |
Min-max | 22–94 |